MTOR and hereditary clear cell renal cell carcinoma: The induction of mTOR by FOXO3 stimulates activation of AKT in renal cell carcinoma, while inhibition of FOXO3 activity enhances the sensitivity of renal cell carcinoma cells to PI3K and AKT inhibitors (63).